Ng Tang Fui S C, Hoffenberg R, Maisey M N, Black E G
Br Med J. 1979 Aug 4;2(6185):298-300. doi: 10.1136/bmj.2.6185.298.
Measurement of serum thyroglobulin (Tg) concentrations and whole-body radioiodine scan were performed simultaneously during follow-up of 32 patients with differentiated thyroid cancer who had undergone thyroid ablation by operation and radioiodine. Almost all patients in whom serum Tg was undetectable had normal scans. Concentrations exceeding 50 ng/ml were invariably associated with residual or metastatic tumour uptake in the scan. Out of 21 observations of detectable values below 50 ng/ml, 14 were in patients whose scans showed subclinical or sub-radiological tumour uptake and seven in patients with normal scans. The sensitivity of serum Tg as a tumour marker compared favourably to that of the whole-body scan. A scan is unnecessary when serum Tg is undetectable, but in patients with detectable serum Tg concentrations, particularly if these are below 50 ng/ml, a scan is important to assess and localise tumour uptake of iodine before advising treatmet with iodine-131.
在对32例已接受手术及放射性碘甲状腺消融术的分化型甲状腺癌患者的随访过程中,同时进行了血清甲状腺球蛋白(Tg)浓度测定和全身放射性碘扫描。几乎所有血清Tg检测不到的患者扫描结果均正常。浓度超过50 ng/ml的情况总是与扫描中残留或转移肿瘤摄取有关。在21次可检测到低于50 ng/ml值的观察中,14次出现在扫描显示亚临床或亚放射性肿瘤摄取的患者中,7次出现在扫描正常的患者中。血清Tg作为肿瘤标志物的敏感性优于全身扫描。当血清Tg检测不到时,无需进行扫描,但对于血清Tg浓度可检测到的患者,尤其是浓度低于50 ng/ml时,在建议用碘-131治疗前,进行扫描对于评估和定位肿瘤碘摄取很重要。